PERCUTANEOUS ABSORPTION PREPARATION

摘要

Percutaneous absorption preparations comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide as an active ingredient together with an external medicine base and satisfying at least one of the following conditions (1) and (2). The preparations realize sustained efficient absorption of 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide with low percutaneous absorption through the skin into the body. (1) Content of active ingredient in a dose of preparation: about 0.1 to about 10 mg, and (2) Size: about 1 to about 300 cm².